# Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19

> **NCT04514627** · NA · COMPLETED · sponsor: **Olive View-UCLA Education & Research Institute** · enrollment: 55 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** Auricular percutaneous neurostimulation

## Key facts

- **NCT ID:** NCT04514627
- **Lead sponsor:** Olive View-UCLA Education & Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-13
- **Primary completion:** 2021-07-31
- **Final completion:** 2022-03-22
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04514627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04514627, "Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04514627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*